Citadel Advisors »

Syros Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 17k 5.35
2023-12-31 $128k 16k 7.79

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Syros Pharmaceuticals

Bain Capital Life Sciences Investors
Artal Group
Adage Capital Partners GP
Samsara BioCapital
Avidity Partners Management
Point72 Asset Management
Flagship Ventures Management
Vanguard Group
Opaleye Management
Goldman Sachs Group
Kennedy Capital Management
Blue Owl Capital Holdings
Walleye Trading Advisors
Millennium Management
BlackRock

View all funds holding Syros Pharmaceuticals